Zosia Kmietowicz1. Show Affiliations » 1. The BMJ.
Abstract
Entities: Chemical
Mesh： See more » Ado-Trastuzumab EmtansineAntineoplastic Agents, Immunological/economicsAntineoplastic Agents, Immunological/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/economicsDrug Approval/economicsDrug Approval/legislation & jurisprudenceDrug Industry/economicsDrug Industry/legislation & jurisprudenceFemaleHumansMaytansine/analogs & derivativesMaytansine/economicsMaytansine/therapeutic useState Medicine/economicsState Medicine/legislation & jurisprudenceTrastuzumab/economicsTrastuzumab/therapeutic useUnited Kingdom
Substances： See more » Antineoplastic Agents, ImmunologicalMaytansineTrastuzumabAdo-Trastuzumab Emtansine
Year: 2017 PMID： 28623237 DOI： 10.1136/bmj.j2930
Source DB: PubMed Journal: BMJ ISSN： 0959-8138